Abstract 1 - DASAIM · 3 Abstract 9 Korresponderende forfatter Ask Tybjærg Nordestgaard Afdeling...
Transcript of Abstract 1 - DASAIM · 3 Abstract 9 Korresponderende forfatter Ask Tybjærg Nordestgaard Afdeling...
1
FOREDRAGSKONKURRENCE
Abstract 1
Korresponderende forfatter ChristianKruseHansenAfdeling AnæstesiologiskAfdelingHospital/institution SjællandsUniversitetshospital,RoskildeMedforfattere MetteDam,ThomasBendtsen,JensBørglumTitel Ultrasound-guidedTransmuscularQuadratusLumborumblockforElectiveCesarean Sectionsignificantlyreducespostoperativeopioidconsumption. Adoubleblindrandomized,controlledtrial
IntroductionThenewmothershouldtakeoptimalcareofthenewbornwiththelowestlevelofpainandtheleastadverseeventsfrompostoperativeopioidsafterElectiveCesareanSection(ECS).Aretrospectivesurveyrevealedavastopioidco-sumptiondespiteamultimodalpainregimen.WeaimedtoinvestigatetheefficacyofbilateralUltrasound-guided(USG)TransmuscularQuadratusLumborum(TQL)blockonpostoperativeopioidconsumptionfollowingECScomparedtoplacebo.
MethodsArandomisedcontrolledanddoubleblindtrialwasconducted.Seventy-twoparturientswereincluded.ECSwasconductedunderspinalanaesthesiaincluding2.5µgsufentanil.ParticipantsreceivedbilateralTQLblockwith2x30mlropivacaine0.375%(Group-RO)orSaline(Group-SA)immediatelyaftersurgery.MorphineconsumptionwasrecordedviaPCA-pumpsandelectronicpatient-files.InjectatewasdepositedintheplanebetweentheQLandpsoasmajormuscles,posteriortothetransversalisfascia(Figure1).StudywasapprovedbyEthicsCommittee,DanishMedicinesAgency&DataProtectionAgencyandmonitoredbyGCP-unit.EudraCT-number2016-004594-41,Clinical-Trials.govID:NCT03068260.
ResultsWefoundstatisticallysignificantandclinicallyrelevantreductionofopioidconsumptionatall6-hour-intervalsuntil24hourspostoperatively.After24postoperativehours,themeandifferencebetweengroupswas29mgoralmorp-hineequivalents.(Confidenceinterval(CI):3-55,p-value<0.04).Group-ROpatientsexperiencedprolongedtimetofirstopioidcomparedtoGroup-SA(Figure2)(p<0.005).Threeoutof34GroupRO-patientsdidnotreceiveanyopioi-dsatall.PainNRSscoremaximumwassignificantlyreducedinGroup-ROpatientsat0-6hours(p<0.005).PONVwasreducedinGroup-RO(3/34)vs.Group-SA(9/34).Noneoftheparticipantsexperiencedlowerlimborbladderparaly-sis,nordetectableaffectionofhemodynamics.
DiscussionBilateralTQLblockresultedinsignificantreductioninopioidconsumptioninpatientsundergoingECSduringthefirst24postoperativehours,asignificantprolongationoftimetofirstopioidandasignificantreductioninpainNRSsco-resduringthefirstsixpostoperativehours.Importantly,noneofthe72participantsexperiencedlowerlimborblad-derparalysis,norhemodynamicinstabilityorsignsofLAsystemictoxicity.Thefewadverseeventsdescribedbytheparticipantswereallrelatedtotheadministrationofopioids.WiththeTQLblock,LAspreadscephaladintotheTPVSthroughthediaphragmaticopeningstoreachandanaesthetisethethoracicsegmentalnervesandsegmentalpartsofthethoracicsympathetictrunk.Belowthediaphragm,LAexertsits’directeffectbyanaesthetisingtheilioinguinal,iliohypogastricandsubcostalnerves,andtosomeextentthegenitofemoralandlateralfemoralcutaneousnerves.
ConclusionsMorphineconsumptionwassignificantlyreducedataclinicallyrelevantleveluntil24postoperativehours.
2
3
Abstract9
Korresponderende forfatter AskTybjærgNordestgaardAfdeling Anæstesi4231,HovedOrtoCentretHospital/institution RigshospitaletMedforfattere LarsS.Rasmussen,MartinH.Sillesen,JacobSteinmetz,HaythamKaafarani, GeorgeC.VelmahosTitel RedBloodCellTransfusioninSurgery:TrendsintheUnitedStatesfrom2011to2016
IntroductionBloodtransfusionmaybelife-saving,butaliberalstrategyisnon-superiortoconservativetransfusionstrategiesinmostsettings.1-3Weexaminedwhetherratesofredbloodcelltransfusionsforsurgicaldiseasehaddeclinedfrom2011to2016intheUnitedStates.
MethodsWeincludeddataonallsurgicalsubspecialtiesfromtheAmericanCollegeofSurgeonsNationalSurgicalQualityIm-provementProgramfrom2011to2016.Aredbloodcelltransfusionwasatransfusionofatleastoneunitintraope-rativelyto72hourspostoperatively.First,weexaminedtheratesoftransfusionsoverthestudyperiod.Second,weexaminedtheparalleltrendsinpreoperativeredbloodcelltransfusions,bleedingdisorders,coagulationimbalances,andminimallyinvasiveprocedures.Third,toaccountforchangesinpopulationandprocedurecharacteristics,weusedmultivariablelogisticregressionstoassesswhethertheriskofreceivingredbloodcelltransfusionshaddecli-ned.Finally,wedeterminedtheoccurrenceofintra-andpostoperativemyocardialinfarctionandstroke.
Results4,273,168patientswereincluded.Redbloodcelltransfusionratesdeclinedfrom8.4%(95%confidenceinterval8.3-8.5)in2011to4.6%(4.6-4.7)(pfortrend<0.001)in2016,consistentinallsubspecialties(Figure1).Preoperati-veredbloodcelltransfusionratesandtheprevalenceofbleedingdisordersdecreasedwhilehematocritlevelsandminimallyinvasiveproceduresincreased.Comparedto2011,theadjustedoddsratiosforredbloodcelltransfusionsdecreasedgraduallyfrom0.88(0.86-0.90)in2012to0.51(0.50-0.51)in2016(pfortrend<0.001)(Figure2).Thecorrespondinghazardratiosforintra-andpostoperativemyocardialinfarctionandstrokewere0.96(0.90-1.02)and0.91(0.83-0.99)in2012and1.05(0.99-1.11)and0.99(0.92-1.07)in2016.
Discussion and conclusionRedbloodcelltransfusionsforsurgicaldiseasedeclinedfrom2011to2016intheUnitedStates.Thiswasconsistentinallsurgicalsubspecialties,andwhenaccountingforvariationinpopulationandprocedurescharacteristics.Weobservednoincreaseintheriskofintra-andpostoperativeischemicoutcomesduringthestudyperiod.
References1)CarsonJLStanworthSJRoubinianN,etal.Transfusionthresholdsandotherstrategiesforguidingallogeneicredbloodcelltransfusion.TheCochranedatabaseofsystematicreviews.2016;(10):CD0020422)AmericanSocietyofAnesthesiologistsTaskForceonPerioperativeBloodM.Practiceguidelinesforperioperativebloodmanagement:anupdatedreportbytheAmericanSocietyofAnesthesiologistsTaskForceonPerioperativeBloodManagement.Anesthesiology.2015;122:241-75.3)CarsonJLGuyattGHeddleNM,etal.ClinicalPracticeGuidelinesFromtheAABB:RedBloodCellTransfusionThres-holdsandStorage.JAMA.2016;316:2025-35.
4
Figure1.Redbloodcelltransfusionrates.
Figure2.Oddsratiosforredbloodcelltransfusionsversus2011.
5
Abstract12
Korresponderende forfatter JannieBisgaardAfdeling AnæstesiologiskAfdelingHospital/institution AalborgUniversitetshospital,OdenseUniversitetshospital,OPENOdensePatient dataExplorativeNetworkMedforfattere R.Madsen,L.Dybdahl,MBMortensen,JTLauridsen,AGJensenTitel Humanalbuminversuskrystalloidvedøvreabdominalcancerkirurgi.
Introduktion Vedøvreabdominalkirurgimedetableringafanastomoserersåvelhyper-somhypovolæmiforbundetmedkompli-kationer.Goal-directedtherapy(GDT),væsketerapivejledtafdynamiskeparametre,bliverbredtanvendtindenforanæstesitilhøjrisikoprocedurer.1Metodenerbaseretpåindgiftafvæskebolusvejledtafpulsepressurevariation(PPV)ogslagvolumen(SV),fremforfastinfusionshastighedellervæskebalance.Istudier,derunderstøttereffektenafGDT,harmantypiskanvendtkolloidtilvæskebolus.Deterdogikkeklart,omboluskrystalloideristandtilatforbed-reoutcomeisammegrad.2EffektenafGDTkanmålessomændringeriindexeretsystemiskiltleverance(sDO2I).Denmesenterielleiltleverance(mDO2I)kanmålesviaDopplerflowia.mesentericasuperior.3ViharundersøgteffektenafGDTmedbolusRingerfundin(RF)versusbolushumanalbumin5%(HA)påsDO2IogmDO2I.
Metoder Randomiseretkliniskstudie,godkendtafVidenskabsetiskKomité(S-20130021).60patientertilelektivøvreabdo-minalcancerkirurgiblevinkluderetograndomiserettilentenbolusHAellerRF.AllepatienterblevmonitoreretmedLiDCOplus-systemetidenintraoperativeperiode.VedtegnpåhypoperfusionogPPV>14%gavmanvæskebolus250ml.Ved<10%stigningiSVeftervæskebolusogfortsattegnpåhypoperfusiongavmanvasopressorellerinotropi.Væsketypenvarblindetforalle,undtagendensygeplejerske,deradministreredevæsken.PrimæreendepunktvarændringerisDO2IogmDO2I.Sekundæreendepunktervarændringeriøvrighæmodynamik,væskebalance,transfusi-oner,komplikationerogindlæggelsestidpåintensivoghospital.
Resultater Viinkluderede60patienterframaj2014tiljuni2015.ResultaterneerpræsenteretiTabel1ogFigur1.DervaringenforskelpåsDO2IellermDO2I.Øvrighæmodynamikvarhellerikkesignifikantafficeret,frasetpuls,dervarmarginaltlavereiHA-gruppen.DerblevgivetmerebolusvæskeiRF-gruppen.Dervarikkeforskelpåtransfusionsbehovet,fore-komstenafkomplikationerellerindlæggelsestidpåintensivellerhospital.
Konklusion GDTmedbolusHAgavikkebedresystemiskellermesenterieliltleveranceendbolusmedRF.TrodsmindreindgiftafbolusvæskeHA-gruppen,varderikkeeffektpåantalletafkomplikationerellerindlæggelsestid.VifinderderforikkeanledningtilatanbefaleHAfremforRFvedGDTtiløvreabdominalcancerkirurgi.
Referencer1.CecconiMetal.Clinicalreview:Goal-directedtherapy-whatistheevidenceinsurgicalpatients?Theeffectondifferentriskgroups.CritCare.2013;17:209.2.RaimanMetal.ComparisonofhydroxyethylstarchcolloidswithcrystalloidsforsurgicalpatientsAsystematicreviewandmeta-analysis.EurJAnaesthesiol.2016;33:42.3.IvaturyRRetal.Aprospectiverandomizedstudyofendpointsofresuscitationaftermajortrauma:globaloxygentransportindicesversusorgan-specificgastricmucosalpH.JAmCollSurg1996,183:145.
6
7
Abstract 13
Korresponderende forfatter KasperH.ThyboAfdeling AnæstesiologiskafdelingHospital/institution NæstvedSygehusMedforfattere Hägi-PedersenD,DahlJB,WetterslevJ,PedersenNA,OvergaardS,BülowHH, SchrøderH,BjørckJG,MathiesenO;onbehalfofallinvestigatorsTitel ParacetamolandNSAIDincombinationforpostoperativeanalgesiaafterprimaryhip arthroplasty:Therandomised,blinded,parallel4-groupPANSAIDclinicaltrial
IntroductionMultimodalpostoperativeanalgesiaisaleadingprincipleformanagementofacutepostoperativepain.Paracetamolandnon-steroidalanti-inflammatorydrugsarefrequentlyusedbutwithnofirmevidenceofbenefitsandharmsoftheircombination.ThePANSAIDtrial’saimwastoinvestigatetheanalgesicandharmfuleffectsoffourmultimodalanalgesicregimenswithparacetamoland/oribuprofenaftertotalhiparthroplasty.
MethodsPANSAIDwasamulticenter,randomized,blinded,placebo-controlled,trialwith90daysfollow-up[1,2].ParticipantswererandomizedtoGroupA:paracetamol1gandibuprofen400mg;B:paracetamol1gandplacebo;C:ibuprofen400mgandplacebo;orD:paracetamol0.5gandibuprofen200mgq.i.d.for24hourspostoperatively,startingonehourpreoperatively.Theco-primaryoutcomeswere:24-hourspatientcontrolledanalgesiamorphineconsumptioninpairwisecomparisonsbetweenthefourgroups;andproportionofpatientswithoneormoremodifiedseriousad-verseevent(SAEs)within90daysingroupsA,CandD(whoallreceivedibuprofen)combinedversusgroupB(recei-vingparacetamolonly).Theminimalimportantdifferencewassetto10mgmorphine(0-24hpostoperatively).
ResultsAll556patientswereanalyzed.Themedian24-hourmorphineconsumptioningroupA,B,C,andDwas20,36,26,and28mg,respectively.Mediandifferencewas16mg(99.6%CI:6.5to24,P<0.001)betweengroupAandB;and8mg(99.6%CI:-1to14,P=0.0011)betweengroupBandD,and6mg(99.6%CI:-2to16,P=0.0024)betweengroupAandC.ThedifferencesbetweengroupAandD(8mg(99.6%CI:-2to16,P=0.0051))andgroupBandC(10mg(99.6%CI:-2to16,P=0.0044))werenotstatisticallysignificantadjustedformultiplecomparisonsandtwoco-primaryout-comes.GroupsCandDdidnotdiffersignificantly.TheproportionofpatientswithSAEsingroupsA+C+Dwas15%(97.5%CI:12to20),and11%(97.5%CI:6to18)ingroupB.TherelativeriskofSAEinthegroupsA+C+DcomparedwithgroupBwas1.44(97.5%CI:0.79to2.45,P=0.18).
Discussion and conclusionGroupA(paracetamol1g+ibuprofen400mg)comparedwithgroupB(paracetamol1g)reducedmorphinecon-sumptionmorethantheminimalimportantdifference.Usingibuprofenthefirstpostoperativedaydoesnotstatisti-callysignificantincreasetheproportionofSAEs(Clinicaltrials.govnumber,NCT02571361).
References1.ThyboKH,Hagi-PedersenD,WetterslevJ,etal.PANSAID-PAracetamolandNSAIDincombination:studyprotocolforarandomisedtrial.Trials2017;18:11.2.ThyboKH,JakobsenJC,Hagi-PedersenD,etal.PANSAID-PAracetamolandNSAIDincombination:detailedstatisti-calanalysisplanforarandomised,blinded,parallel,four-groupmulticentreclinicaltrial.Trials2017;18:465.
8
Abstract17
Korresponderende forfatter TobiasLyngeraaAfdeling AnæstesiologiskafdelingHospital/institution NordsjællandsHospitalMedforfattere PiaJæger,BoGottschau,BenGraungaard,AnjaRossen-Jørgensen,IbenToftegaard, UlrikGrevstadTitel Analgesiceffectofanadductorcanalblockusingasuture-methodcathetervsa standardperineuralcathetervsasinglebolus:ablinded,randomized,controlled study
Background and AimsWeaimedtoinvestigatetheanalgesiceffectoftwodifferentcathetersforacontinuousadductorcanalblock(ACB)—anewsuture-methodcatheterandastandardperineuralcatheter—comparedwithasinglebolusACB.
MethodsWeperformedarandomized,blinded,controlledstudy,includingadultpatientsscheduledforprimarykneearthrop-lastywithspinalanesthesia.AllpatientsreceivedanACBwithaninitialbolusof20ml0.75%ropivacaine,followedbynobolus(singlebolusgroup)or20mlof0.2%ropivacaineevery8hours(standardandsuture-methodcathetergroups).Theprimaryoutcomewastotalopioidconsumptionfromendofsurgeryuntilpostoperativeday(POD)2.Secondaryoutcomeswerepainscores,musclestrengthandambulation.EthicsCommitteesapproval:H-17001589.Clinicaltrial.gov.ID:NCT03142789.
ResultsWerandomized153patientsofwhom153wereanalyzed.TotalopioidconsumptiononPOD2wasamedian(ran-ge)of37mg(0–158)inthesinglebolusgroup,38mg(0–123)inthestandardgroupand24mg(0–148)inthesu-ture-methodgroup(P=0.049),buttherewerenostatisticallysignificantdifferencesintheindividualanalysesafterBonferronicorrection(α=0.05/3).TherewerenodifferencesbetweengroupsonPOD1.OnPOD2therewerenodifferencesbetweenthecathetergroups,butambulationandmusclestrengthwereimprovedcomparedwiththebolusgroup(P<0.05/18,table1).
ConclusionsProvidingrepeatedbolusesviaacatheterdidnotdecreaseopioidconsumptionorpaincomparedwithasinglebolus,butdidimproveambulationandmusclestrengthonPOD2.Therewerenostatisticallysignificantdifferencesbet-weenthetwotypesofcatheters.
9
Abstract2
Korresponderende forfatter MetteDamAfdeling AnæstesiologiskafdHospital/institution SjællandsuniversitetshospitalRoskildeMedforfattere HansenCK,PoulsenTD,AzawiNHM,WolmaransM,ChanV,LaierGH,BendtsenTF, BørglumJTitel UnilateralTransmuscularQuadratusLumborum(TQL)blockreducesopioid consumptionandfacilitatesearlydischargefromhospitalafterpercutaneous operationforlargekidneystones;Adouble-blindRCT
BackgroundPercutaneousNephrolithotomy(PNL)surgeryisoftenassociatedwithseverepostoperativepain.Theaimofthecurrentstudywastoinvestigatetheanalgesicefficacyoftransmuscularquadratuslumborum(TQL)blockforpatientsundergoingPNLsurgery.
MethodsApprovedbyRegionalEthicsCommittee&DanishMedicineAgency.RegisteredatClinicalTrialsNCT02818140.60patientsASA1-3wereenrolledinthestudy.AllpatientsscheduledforelectivePNLundergeneralanaesthesiawithpropofolandremifentanil.Allpatientsreceivedastandardizedmultimodalanalgesicregimeconsistingoforalaceta-minophen1g,dexamethasone4mg&0.25µg/kgsufentanilI.V.30minutespriortoemergence.AllpatientshadaPatientControlledAnalgesic(PCA)pumpinthestudyperiod:thefirst24postoperativehours.PatientswereallocatedtoapreoperativeTQLblockwitheitherropivacaine30ml0.75%or30mlsaline.Primaryoutcome:Morphinecon-sumption0-6postoperativehours.Secondaryoutcomes:Morphineconsumption6-12,12-18,18-24postoperativehours,accumulatedopioidconsumption24hourspostoperatively,timetofirstopioid,ambulationtime,lengthofstay(LOS)Dischargetime.
10
ResultsOralmorphineequivalentsadministered0-6hourmean±SD7.5(8.7)vs.90.6(69.9)mg,p<0.0001wassignificantlyreducedintheinterventiongroupcomparedtocontrol.Asignificantreductioninaccumulatedoralmorphineequiva-lentsininterventiongroupfor24hourswasrecorded(Table1).Timetofirstopioidmean±SD647.3(402.7)vs.39.1(23.7)minutes,p<0.0001wassignificantlyprolongedininterven-tiongroup(Figure1),andinterventiongroupwasabletoambulatesignificantlyearliermean±SD365.7(254.5)vs.636.2(366.2)minutes,p<0.004).LOSwassignificantlyshorterintheinterventiongroupmean(days)±SD2.00(0.78)vs3.03(1.25)p=0.001comparedtocontrol.
ConclusionUnilateralTQLblocksignificantlyreducesthepostoperativeopioidconsumptionandfacilitatessignificantlyearlierdischargefromhospital.
Legend Figure 1Kaplan-Meiersurvivalplotoftimetofirstopioid(minutes),definedastimefromT0untilfirstrequestforopioid.